Published in Mol Pharmacol on January 13, 2017
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature (1994) 10.95
Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell (2002) 10.81
TEAD mediates YAP-dependent gene induction and growth control. Genes Dev (2008) 9.88
Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol (2002) 9.25
Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16
Reflecting on 25 years with MYC. Nat Rev Cancer (2008) 7.44
14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol (2000) 6.94
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev (2000) 6.54
The I-TASSER Suite: protein structure and function prediction. Nat Methods (2015) 6.17
Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev (2001) 5.41
The BioGRID interaction database: 2015 update. Nucleic Acids Res (2014) 4.06
A proteome-scale map of the human interactome network. Cell (2014) 3.91
A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods (2006) 3.73
Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. Proc Natl Acad Sci U S A (1997) 3.46
Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc Natl Acad Sci U S A (2002) 3.15
Detecting protein-protein interactions with a green fluorescent protein fragment reassembly trap: scope and mechanism. J Am Chem Soc (2005) 2.95
Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J Virol (1982) 2.89
Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation. Anal Chem (2003) 2.72
Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol (2012) 2.53
Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc (2009) 2.27
Universal strategies in research and drug discovery based on protein-fragment complementation assays. Nat Rev Drug Discov (2007) 2.20
Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J (2004) 2.19
14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem (2001) 2.04
Proteomic profiling of Myc-associated proteins. Cell Cycle (2010) 1.80
Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci U S A (2008) 1.69
Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci U S A (2007) 1.62
Detection of protein-protein interactions by protein fragment complementation strategies. Methods Enzymol (2000) 1.51
MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors. PLoS One (2011) 1.38
Structure of an ultraweak protein-protein complex and its crucial role in regulation of cell morphology and motility. Mol Cell (2005) 1.37
Bimolecular fluorescence complementation (BiFC): a 5-year update and future perspectives. Biotechniques (2012) 1.32
Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer. Biochem Biophys Res Commun (2013) 1.17
Exploring protein interactions by interaction-induced folding of proteins from complementary peptide fragments. Curr Opin Struct Biol (2001) 1.16
Inhibitor of MYC identified in a Kröhnke pyridine library. Proc Natl Acad Sci U S A (2014) 1.14
Adding protein context to the human protein-protein interaction network to reveal meaningful interactions. PLoS Comput Biol (2013) 1.10
BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. J Proteomics (2014) 1.07
Myc and its interactors take shape. Biochim Biophys Acta (2014) 1.03
The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss. Oncogene (2014) 1.01
An infrared reporter to detect spatiotemporal dynamics of protein-protein interactions. Nat Methods (2014) 0.98
Discovering protein-protein interactions within the programmed cell death network using a protein-fragment complementation screen. Cell Rep (2014) 0.89
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells. ACS Chem Biol (2015) 0.88
Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Oncogene (2014) 0.85
The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation. Mol Cell Biol (2012) 0.84
Self-Assembling NanoLuc Luciferase Fragments as Probes for Protein Aggregation in Living Cells. ACS Chem Biol (2015) 0.82
A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors. Assay Drug Dev Technol (2013) 0.82
Overexpression of the LKB1 gene inhibits lung carcinoma cell proliferation partly through degradation of c-myc protein. Oncol Rep (2009) 0.82
Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform. J Mol Cell Biol (2015) 0.77
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun (2017) 0.77
BRET: NanoLuc-Based Bioluminescence Resonance Energy Transfer Platform to Monitor Protein-Protein Interactions in Live Cells. Methods Mol Biol (2016) 0.76